Richard Braverman

1.2k total citations
17 papers, 996 citations indexed

About

Richard Braverman is a scholar working on Molecular Biology, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Richard Braverman has authored 17 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Cell Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Richard Braverman's work include RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Richard Braverman is often cited by papers focused on RNA modifications and cancer (3 papers), RNA and protein synthesis mechanisms (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Richard Braverman collaborates with scholars based in United States, India and Netherlands. Richard Braverman's co-authors include Herbert L. Cooper, William C. Vass, J.E. Folk, B Safer, Douglas R. Lowy, Alex G. Papageorge, Xiaolan Qian, Laura Asnaghi, Shaowei Li and Jeffrey E. DeClue and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Richard Braverman

17 papers receiving 964 citations

Peers

Richard Braverman

PHYSI

ONCOL

BIOCH

Russell Bandle United States

Venugopal D. Talkad United States

Jonathan Hurov United States

Jürgen Scheele Germany

Leslie A. Serunian United States

E Lee United States

Roberta Fiume Italy

Marı́a J. Caloca Spain

Ursula Vogel United States

M Kawata Japan

Russell Bandle United States

Richard Braverman

855 ×1.1

267 ×1.1

111 ×0.7

PHYSI

125 ×1.0

ONCOL

51 ×0.5

BIOCH

Citations per year, relative to Richard Braverman Richard Braverman (= 1×) peers Russell Bandle

Countries citing papers authored by Richard Braverman

Since Specialization

Citations

This map shows the geographic impact of Richard Braverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Braverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Braverman more than expected).

Fields of papers citing papers by Richard Braverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Braverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Braverman. The network helps show where Richard Braverman may publish in the future.

Co-authorship network of co-authors of Richard Braverman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Braverman. A scholar is included among the top collaborators of Richard Braverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Braverman. Richard Braverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Du, Xiaoli, Xiaolan Qian, Alex G. Papageorge, et al.. (2012). Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells. Cancer Research. 72(17). 4405–4416. 42 indexed citations

Asnaghi, Laura, William C. Vass, Rafael Quadri, et al.. (2010). E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene. 29(19). 2760–2771. 61 indexed citations

Qian, Xiaolan, Guorong Li, Holly Asmussen, et al.. (2007). Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proceedings of the National Academy of Sciences. 104(21). 9012–9017. 147 indexed citations

Li, Shaowei, Richard Braverman, Hongzhen Li, et al.. (2003). Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E‐cadherin/β‐catenin activity. Molecular Carcinogenesis. 37(2). 98–109. 9 indexed citations

Benvenuto, Giovanna, Shaowei Li, Richard Braverman, et al.. (2000). The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene. 19(54). 6306–6316. 203 indexed citations

Shah, Vanya, Richard Braverman, & G. L. Prasad. (1998). Suppression of Neoplastic Transformation and Regulation of Cytoskeleton by Tropomyosins. Somatic Cell and Molecular Genetics. 24(5). 273–280. 24 indexed citations

Prasad, G. L., et al.. (1994). Expression, Cytoskeletal Utilization and Dimer Formation of Tropomyosin Derived from Retroviral‐Mediated cDNA Transfer. European Journal of Biochemistry. 224(1). 1–10. 20 indexed citations

Cooper, Herbert L., et al.. (1991). T cell receptor activation induces rapid phosphorylation of prosolin, which mediates down-regulation of DNA synthesis in proliferating peripheral lymphocytes. The Journal of Immunology. 146(11). 3689–3696. 32 indexed citations

Cooper, Herbert L., et al.. (1990). A specific defect of prosolin phosphorylation in T cell leukemic lymphoblasts is associated with impaired down-regulation of DNA synthesis.. The Journal of Immunology. 145(4). 1205–1213. 19 indexed citations

10.

Cooper, Herbert L., et al.. (1989). Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin.. The Journal of Immunology. 143(3). 956–963. 49 indexed citations

11.

Braverman, Richard, Bhaswati Bhattacharya, Nili Feuerstein, & Herbert L. Cooper. (1986). Identification and characterization of the nonphosphorylated precursor of pp17, a phosphoprotein associated with phorbol ester induction of growth arrest and monocytic differentiation in HL-60 promyelocytic leukemia cells.. Journal of Biological Chemistry. 261(30). 14342–14348. 55 indexed citations

12.

Cooper, Herbert L., et al.. (1983). Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D.. Proceedings of the National Academy of Sciences. 80(7). 1854–1857. 184 indexed citations

13.

Cooper, Herbert L. & Richard Braverman. (1981). Close correlation between initiator methionyl-tRNA level and rate of protein synthesis during human lymphocyte growth cycle.. Journal of Biological Chemistry. 256(14). 7461–7467. 19 indexed citations

14.

Cooper, Herbert L. & Richard Braverman. (1980). Protein synthesis in resting and growth-stimulated human peripheral lymphocytes. Experimental Cell Research. 127(2). 351–359. 11 indexed citations

15.

Cooper, Herbert L. & Richard Braverman. (1977). The mechanism by which actinomycin D inhibits protein synthesis in animal cells. Nature. 269(5628). 527–529. 45 indexed citations

16.

Cooper, Herbert L. & Richard Braverman. (1977). Free ribosomes and growth stimulation in human peripheral lymphocytes: Activation of free ribosomes as an essential event in growth induction. Journal of Cellular Physiology. 93(2). 213–225. 35 indexed citations

17.

Cooper, Herbert L., Shelby L. Berger, & Richard Braverman. (1976). Free ribosomes in physiologically nondividing cells. Human peripheral lymphocytes.. Journal of Biological Chemistry. 251(16). 4891–4900. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact